274 related articles for article (PubMed ID: 18319307)
41. Congenital adrenal hyperplasia. Molecular characterization.
Ko TM; Kao CH; Ho HN; Tseng LH; Hwa HL; Hsu PM; Chuang SM; Lee TY
J Reprod Med; 1998 Apr; 43(4):379-86. PubMed ID: 9583072
[TBL] [Abstract][Full Text] [Related]
42. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.
Wilson RC; Mercado AB; Cheng KC; New MI
J Clin Endocrinol Metab; 1995 Aug; 80(8):2322-9. PubMed ID: 7629224
[TBL] [Abstract][Full Text] [Related]
43. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: genotype-phenotype correlation].
Mendes C; Vaz Matos I; Ribeiro L; Oliveira MJ; Cardoso H; Borges T
Acta Med Port; 2015; 28(1):56-62. PubMed ID: 25817499
[TBL] [Abstract][Full Text] [Related]
44. Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.
Janner M; Pandey AV; Mullis PE; Flück CE
Eur J Endocrinol; 2006 Jul; 155(1):143-51. PubMed ID: 16793961
[TBL] [Abstract][Full Text] [Related]
45. CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency.
Witchel SF; Smith R; Crivellaro CE; Della Manna T; Dichtchekenian V; Setian N; Damiani D
Hum Genet; 2000 Apr; 106(4):414-9. PubMed ID: 10830908
[TBL] [Abstract][Full Text] [Related]
46. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
[TBL] [Abstract][Full Text] [Related]
47. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
48. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.
Nunez BS; Lobato MN; White PC; Meseguer A
Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376
[TBL] [Abstract][Full Text] [Related]
49. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.
Ferenczi A; Garami M; Kiss E; Pék M; Sasvári-Székely M; Barta C; Staub M; Sólyom J; Fekete G
J Clin Endocrinol Metab; 1999 Jul; 84(7):2369-72. PubMed ID: 10404805
[TBL] [Abstract][Full Text] [Related]
50. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
Pasqualini T; Alonso G; Tomasini R; Galich AM; Buzzalino N; Fernandez C; Minutolo C; Alba L; Dain L
Medicina (B Aires); 2007; 67(3):253-61. PubMed ID: 17628913
[TBL] [Abstract][Full Text] [Related]
51. Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency.
Nikoshkov A; Lajic S; Holst M; Wedell A; Luthman H
J Clin Endocrinol Metab; 1997 Jan; 82(1):194-9. PubMed ID: 8989258
[TBL] [Abstract][Full Text] [Related]
52. [Mutation analysis in families with 21-hydroxylase deficiency].
Wang H; Jiang L; Wang PP; Zhou HB; Wang JL; Song LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):681-4. PubMed ID: 18067083
[TBL] [Abstract][Full Text] [Related]
53. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Madureira G; Marcondes JA; Longui CA; Leite MV; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 1998 Dec; 83(12):4416-9. PubMed ID: 9851787
[TBL] [Abstract][Full Text] [Related]
54. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Speiser PW; Dupont J; Zhu D; Serrat J; Buegeleisen M; Tusie-Luna MT; Lesser M; New MI; White PC
J Clin Invest; 1992 Aug; 90(2):584-95. PubMed ID: 1644925
[TBL] [Abstract][Full Text] [Related]
55. The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions.
Krone N; Riepe FG; Grötzinger J; Partsch CJ; Brämswig J; Sippell WG
J Mol Med (Berl); 2005 Jul; 83(7):561-8. PubMed ID: 15830218
[TBL] [Abstract][Full Text] [Related]
56. Novel mutations in CYP21 detected in individuals with hyperandrogenism.
Lajić S; Clauin S; Robins T; Vexiau P; Blanché H; Bellanne-Chantelot C; Wedell A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2824-9. PubMed ID: 12050257
[TBL] [Abstract][Full Text] [Related]
57. [Characterization of steroid 21-hydroxylase gene mutations in a oligosymptomatic form of congenital adrenal hyperplasia: family study].
Martínez Olmos MA; Varela JM; Ezquieta B; Hillman N; Díez JJ
Med Clin (Barc); 1997 Oct; 109(11):421-4. PubMed ID: 9379733
[TBL] [Abstract][Full Text] [Related]
58. Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.
Yang YP; Corley N; Garcia-Heras J
Mol Diagn; 2001 Sep; 6(3):193-9. PubMed ID: 11571713
[TBL] [Abstract][Full Text] [Related]
59. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.
Araújo RS; Mendonca BB; Barbosa AS; Lin CJ; Marcondes JA; Billerbeck AE; Bachega TA
J Clin Endocrinol Metab; 2007 Oct; 92(10):4028-34. PubMed ID: 17666484
[TBL] [Abstract][Full Text] [Related]
60. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.
Barbat B; Bogyo A; Raux-Demay MC; Kuttenn F; Boué J; Simon-Bouy B; Serre JL; Mornet E
Hum Mutat; 1995; 5(2):126-30. PubMed ID: 7749410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
